15-Year watch: tracking patients after experimental cell therapy for blood cancer
NCT ID NCT03741127
Summary
This study is tracking patients for 15 years after they received an experimental cell therapy called P-BCMA-101 for multiple myeloma, a type of blood cancer. The goal is to monitor for any long-term side effects and see how well the treatment continues to work over time. It is for people who have already been treated with P-BCMA-101 in a previous Poseida-sponsored trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Johns Hopkins University
Baltimore, Maryland, 21205, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Sarah Cannon Research Institute at Tennessee Oncology
Nashville, Tennessee, 37203, United States
-
University of California Davis
Davis, California, 95618, United States
-
University of California San Francisco
San Francisco, California, 94143, United States
-
University of California, San Diego
San Diego, California, 92121, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Kansas Cancer Center
Westwood, Kansas, 66205, United States
-
University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, 21201, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37203, United States
-
Wayne State - Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
Conditions
Explore the condition pages connected to this study.